×
<- Back

Low dose methotrexate for the treatment of inflammatory arthritis

Speciality Classification
Pharmacists
Location
Online
Delivery
Online
Duration
1 hour

Starts 1:00pm Wednesday, 11 November 2020

Ends 2:00pm Wednesday, 11 November 2020

Type Webinar

Low dose Methotrexate is the first line treatment of choice for most patients with inflammatory arthritis. This webinar will provide an overview of the pathophysiology of these conditions, ‘explode’ the myths associated with the use of methotrexate and outline key practice points for pharmacists to consider when they are interacting with patients with inflammatory arthritis.

This webinar will commence at 1:00pm AEDT

Registration rate: Free

Speaker: 

  • Professor Susanna Proudman, Head of Rheumatology, Royal Adelaide Hospital, SA

Competency Standards:

The program addresses the following pharmacy competency standards:

  • Standard 2.2.3 Promote effective interprofessional practice
  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.1.3 Collaborate to develop a medication management strategy or plan

National Competency Standards Framework for Pharmacists in Australia, 2016

Accreditation:

This activity has been accredited for 1 hour of Group-1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan.

Type
Delivery
Title
Low dose methotrexate for the treatment of inflammatory arthritis
Speciality Classification
Interest Areas / Topics Covered
Hospital Medicine, Preventive healthcare | medicine, Rheumatology, Oral Pathology and Oral Medicine
Location
Provider Type
Education Provider
Duration
1 hour
Start Date
11-Nov-2020
End Date
11-Nov-2020
CPD Points
1
Price
Free
Price Details
Registration Needed
Location
Online
Contact Phone
Log in into view this field.
98 Views
Price: FreeRegistration Needed
Similar Listings
HealthcareLink